| Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011 | 903 | 2011 |
| Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies RL Bowman, F Klemm, L Akkari, SM Pyonteck, L Sevenich, DF Quail, ... Cell reports 17 (9), 2445-2459, 2016 | 603 | 2016 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ... Clinical Pharmacology & Therapeutics 90 (2), 328-332, 2011 | 598 | 2011 |
| Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis EE Gardner, BH Lok, VE Schneeberger, P Desmeules, LA Miles, ... Cancer cell 31 (2), 286-299, 2017 | 482 | 2017 |
| CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer K Weiskopf, NS Jahchan, PJ Schnorr, S Cristea, AM Ring, RL Maute, ... The Journal of clinical investigation 126 (7), 2610-2620, 2016 | 442 | 2016 |
| PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer BH Lok, EE Gardner, VE Schneeberger, A Ni, P Desmeules, N Rekhtman, ... Clinical Cancer Research 23 (2), 523-535, 2017 | 333 | 2017 |
| DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2 JT Poirier, EE Gardner, N Connis, AL Moreira, E De Stanchina, CL Hann, ... Oncogene 34 (48), 5869-5878, 2015 | 246 | 2015 |
| P-selectin is a nanotherapeutic delivery target in the tumor microenvironment Y Shamay, M Elkabets, H Li, J Shah, S Brook, F Wang, K Adler, E Baut, ... Science translational medicine 8 (345), 345ra87-345ra87, 2016 | 208 | 2016 |
| Noninvasive interrogation of DLL3 expression in metastatic small cell lung cancer SK Sharma, J Pourat, D Abdel-Atti, SD Carlin, A Piersigilli, AJ Bankovich, ... Cancer research 77 (14), 3931-3941, 2017 | 115 | 2017 |
| Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus LA Miles, LN Burga, EE Gardner, M Bostina, JT Poirier, CM Rudin The Journal of clinical investigation 127 (8), 2957-2967, 2017 | 82 | 2017 |
| Rapamycin rescues ABT-737 efficacy in small cell lung cancer EE Gardner, N Connis, JT Poirier, L Cope, I Dobromilskaya, GL Gallia, ... Cancer research 74 (10), 2846-2856, 2014 | 66 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clin Pharmacol Ther 89 (3), 387-391, 2011 | 61 | 2011 |
| Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer RL Zinn, EE Gardner, I Dobromilskaya, S Murphy, L Marchionni, CL Hann, ... Molecular cancer 12, 1-10, 2013 | 59 | 2013 |
| Quantitation of murine stroma and selective purification of the human tumor component of patient-derived xenografts for genomic analysis VE Schneeberger, V Allaj, EE Gardner, JT Poirier, CM Rudin PloS one 11 (9), e0160587, 2016 | 57 | 2016 |
| Clinical pharmacogenetics implementation consortium: clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel … SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ... Clin Pharmacol Ther 90 (2), 328-332, 2011 | 52 | 2011 |
| ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer RL Zinn, EE Gardner, L Marchionni, SC Murphy, I Dobromilskaya, ... Molecular cancer therapeutics 12 (6), 1131-1139, 2013 | 45 | 2013 |
| Lineage-specific intolerance to oncogenic drivers restricts histological transformation EE Gardner, EM Earlie, K Li, J Thomas, MJ Hubisz, BD Stein, C Zhang, ... Science 383 (6683), eadj1415, 2024 | 30 | 2024 |
| Role of mTOR as an essential kinase in SCLC JA Kern, J Kim, DG Foster, R Mishra, EE Gardner, JT Poirier, C Rivard, ... Journal of Thoracic Oncology 15 (9), 1522-1534, 2020 | 17 | 2020 |
| Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis A Vaishnavi, J Juan, M Jacob, C Stehn, EE Gardner, MT Scherzer, ... Cancer research 82 (22), 4261-4273, 2022 | 14 | 2022 |
| Generation of precision preclinical cancer models using regulated in vivo base editing A Katti, A Vega-Pérez, M Foronda, J Zimmerman, MP Zafra, E Granowsky, ... Nature Biotechnology 42 (3), 437-447, 2024 | 13 | 2024 |
Charles RudinChief, Thoracic Oncology, Memorial Sloan Kettering Cancer CenterE-mailová adresa ověřena na: mskcc.org